To lower drug costs at home, Trump wants higher prices abroad

9 May 2018 - People who work in the industry said it was unlikely that consumers would go to the pharmacy ...

Read more →

Forty Seven granted fast track designation for 5F9 for the treatment of diffuse large B-cell lymphoma and follicular lymphoma

3 May 2018 - Forty Seven today announced that the U.S. FDA has granted two fast track designations to its lead ...

Read more →

Evaluating and valuing drugs for rare conditions: no easy answers

9 May 2018 - We find ourselves in an era of unprecedented growth in the development and use of so-called “orphan” ...

Read more →

FDA grants fast track designation to Debiopharm's Debio 1347 for the treatment of patients with unresectable or metastatic tumours with a specific FGFR gene alteration

8 May 2018 - Debiopharm  announced today that the U.S. FDA has granted fast track designation to Debio 1347, an ...

Read more →

Relypsa announces FDA approval of supplemental new drug application to enable the usage of Veltassa (patiromer) with or without food

8 May 2018 - Updated label may allow for increased dosing flexibility for patients with hyperkalaemia – a chronic, asymptomatic condition ...

Read more →

Transparency on quality and price will transform medicine

9 May 2018 - Transparency is becoming a fashionable buzzword in many walks of life.  ...

Read more →

Aligning price and value for drugs—potential disrupters of the PBM model

7 May 2018 - When the latest version of the iPhone comes out, customers can judge whether the price is "worth ...

Read more →

Here's what to expect when Trump outlines his policy to bring down drug prices

7 May 2018 - Alex Azar, Health and Human Services secretary, said in a speech last week that "the entire system ...

Read more →

Trump often goes off script. What does that mean for his drug pricing speech?

7 May 2018 - President Trump is expected to deliver a major address on drug prices this week. And perhaps ...

Read more →

Generic price competition for specialty drugs: too little, too late?

7 May 2018 - The case of generic imatinib demonstrates several potential barriers to effective generic price competition for specialty prescription ...

Read more →

First US drug priced at more than $1 million may be on the horizon

7 May 2018 - New gene therapies that aim to cure haemophilia, a disease affecting the blood's ability to clot, are ...

Read more →

Gnawing away at health care

7 May 2018 - At the beginning of 2017, Republicans promised to release the kraken on Obamacare — to destroy ...

Read more →

Precision medicines have faster approvals based on fewer and smaller trials than other medicines

7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...

Read more →

FDA approves supplemental new drug application for Myrbetriq (mirabegron) for use in combination with solifenacin succinate for the treatment of overactive bladder symptoms

7 May 2018 - Astellas announced today that the U.S. FDA has approved a supplemental new drug application for the ...

Read more →

Salix receives FDA approval for Plenvu, next generation 1 litre bowel cleansing preparation for colonoscopies

7 May 2018 - Salix Pharmaceuticals and its partner Norgine announced today that the U.S. FDA has approved Plenvu (polyethylene glycol ...

Read more →